» Articles » PMID: 21947082

USP15 is a Deubiquitylating Enzyme for Receptor-activated SMADs

Overview
Journal Nat Cell Biol
Specialty Cell Biology
Date 2011 Sep 28
PMID 21947082
Citations 121
Authors
Affiliations
Soon will be listed here.
Abstract

The TGFβ pathway is critical for embryonic development and adult tissue homeostasis. On ligand stimulation, TGFβ and BMP receptors phosphorylate receptor-activated SMADs (R-SMADs), which then associate with SMAD4 to form a transcriptional complex that regulates gene expression through specific DNA recognition. Several ubiquitin ligases serve as inhibitors of R-SMADs, yet no deubiquitylating enzyme (DUB) for these molecules has so far been identified. This has left unexplored the possibility that ubiquitylation of R-SMADs is reversible and engaged in regulating SMAD function, in addition to degradation. Here we identify USP15 as a DUB for R-SMADs. USP15 is required for TGFβ and BMP responses in mammalian cells and Xenopus embryos. At the biochemical level, USP15 primarily opposes R-SMAD monoubiquitylation, which targets the DNA-binding domains of R-SMADs and prevents promoter recognition. As such, USP15 is critical for the occupancy of endogenous target promoters by the SMAD complex. These data identify an additional layer of control by which the ubiquitin system regulates TGFβ biology.

Citing Articles

Ectopic USP15 expression inhibits HIV-1 transcription involving changes in YY1 deubiquitination and stability.

Rezaei S, Timani K, Liu Y, He J Front Cell Infect Microbiol. 2024; 14():1371655.

PMID: 39624264 PMC: 11609158. DOI: 10.3389/fcimb.2024.1371655.


Knocking out USP7 attenuates cardiac fibrosis and endothelial-to-mesenchymal transition by destabilizing SMAD3 in mice with heart failure with preserved ejection fraction.

Yuan S, Wang Z, Yao S, Wang Y, Xie Z, Wang J Theranostics. 2024; 14(15):5793-5808.

PMID: 39346543 PMC: 11426239. DOI: 10.7150/thno.97767.


Global isonicotinylome analysis identified SMAD3 isonicotinylation promotes liver cancer cell epithelial-mesenchymal transition and invasion.

Li Y, Jiang Y, Yan H, Qin Z, Peng Y, Lv D iScience. 2024; 27(9):110775.

PMID: 39286495 PMC: 11403401. DOI: 10.1016/j.isci.2024.110775.


In vivo CRISPR screens reveal SCAF1 and USP15 as drivers of pancreatic cancer.

Martinez S, Wu S, Geuenich M, Malik A, Weber R, Woo T Nat Commun. 2024; 15(1):5266.

PMID: 38902237 PMC: 11189927. DOI: 10.1038/s41467-024-49450-3.


Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors.

Runa F, Ortiz-Soto G, de Barros N, Kelber J Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543112 PMC: 10975212. DOI: 10.3390/ph17030326.


References
1.
Itoh S, Ten Dijke P . Negative regulation of TGF-beta receptor/Smad signal transduction. Curr Opin Cell Biol. 2007; 19(2):176-84. DOI: 10.1016/j.ceb.2007.02.015. View

2.
Lonn P, Moren A, Raja E, Dahl M, Moustakas A . Regulating the stability of TGFbeta receptors and Smads. Cell Res. 2008; 19(1):21-35. DOI: 10.1038/cr.2008.308. View

3.
Inman G, Nicolas F, Hill C . Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. Mol Cell. 2002; 10(2):283-94. DOI: 10.1016/s1097-2765(02)00585-3. View

4.
Dupont S, Zacchigna L, Cordenonsi M, Soligo S, Adorno M, Rugge M . Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell. 2005; 121(1):87-99. DOI: 10.1016/j.cell.2005.01.033. View

5.
Fontemaggi G, Gurtner A, Strano S, Higashi Y, Sacchi A, Piaggio G . The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation. Mol Cell Biol. 2001; 21(24):8461-70. PMC: 100009. DOI: 10.1128/MCB.21.24.8461-8470.2001. View